Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Thrombolysis in stroke mimics : frequency, clinical characteristics, and outcome
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 1194861
Author(s) Winkler, David T; Fluri, Felix; Fuhr, Peter; Wetzel, Stephan G; Lyrer, Philippe A; Ruegg, Stephan; Engelter, Stefan T
Author(s) at UniBasel Rüegg, Stephan
Fuhr, Peter
Engelter, Stefan
Year 2009
Title Thrombolysis in stroke mimics : frequency, clinical characteristics, and outcome
Journal Stroke : a journal of cerebral circulation : journal of the American Heart Association
Volume 40
Number 4
Pages / Article-Number 1522-5
Keywords epilepsy, global asphasia without hemiparesis, stroke, stroke mimics, thrombolysis
Abstract BACKGROUND AND PURPOSE: Intravenous thrombolysis for acute ischemic stroke is usually based on clinical assessment, blood test results, and CT findings. Intravenous thrombolysis of stroke mimics may occur but has not been studied in detail. METHODS: We determined frequency, clinical characteristics, and outcome of mimic patients versus patients with stroke treated with intravenous thrombolysis using data of a prospective, single-center thrombolysis data bank. RESULTS: Among 250 patients, 243 (97.2%) had strokes and 7 (2.8%) were mimics. Seizure was the most frequent diagnosis among mimics. There was a trend toward lower National Institutes of Health Stroke Scale scores in mimics (9.9+/-4.2) compared with strokes (13.7+/-5.4; P=0.06). Global aphasia without hemiparesis was the presenting symptom in 3 (42.9%) mimics versus 8 (3.3%) strokes (P=0.002). Orolingual angioedema, symptomatic intracranial hemorrhage, and asymptomatic intracranial hemorrhage occurred in 3 (1.2%), 13 (5.3%), and 30 (12.3%) patients with stroke, but were absent in mimics. After 3 months, 6 (85.7%) mimics and 86 (35.4%) strokes had a modified Rankin Scale score of 0 to 1 (P=0.01). CONCLUSIONS: Only few patients receiving intravenous thrombolysis did eventually have a final diagnosis other than stroke, ie, mostly seizures. Their outcome was favorable. Although clinical features differed between the stroke and the mimic groups, the differences were not distinctive enough to allow assigning individual patients to either of the groups. Multimodal neuroimaging or electroencephalographic recordings may be helpful for this assignment. However, their potential benefit has to be weighed against the potential harm of delayed thrombolysis.
Publisher American Heart Association
ISSN/ISBN 0039-2499
edoc-URL http://edoc.unibas.ch/dok/A6005059
Full Text on edoc No
Digital Object Identifier DOI 10.1161/STROKEAHA.108.530352
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/19164790
ISI-Number WOS:000264709500080
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.342 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
10/05/2024